All Stories

  1. Biomarkers of potential harm in people switching from smoking tobacco to exclusive e‐cigarette use, dual use or abstinence: secondary analysis of Cochrane systematic review of trials of e‐cigarettes for smoking cessation
  2. A framework for considering the utility of models when facing tough decisions in public health: a guideline for policy-makers
  3. Impact of prenatal alcohol exposure on neurodevelopmental outcomes: a systematic review
  4. Knowledge, Attitudes, and Practices Towards Fetal Alcohol Spectrum Disorder in New Zealand Educators: An Online Survey
  5. The association between vaping and health behaviors among undergraduate college students in the United States
  6. Identifying prospective subpopulations of combustible and electronic cigarette dual users in the United States via finite mixture modeling
  7. Adapting an Evidence-Based e-Learning Cognitive Behavioral Therapy Program Into a Mobile App for People Experiencing Gambling-Related Problems: Formative Study
  8. Lower-Risk Cannabis Use Guidelines (LRCUG) for reducing health harms from non-medical cannabis use: A comprehensive evidence and recommendations update
  9. Recruitment and Retention of Parents of Adolescents in a Text Messaging Trial (MyTeen): Secondary Analysis From a Randomized Controlled Trial
  10. A Pragmatic Randomized Comparative Trial of e-Cigarettes and Other Nicotine Products for Quitting or Long-Term Substitution in Smokers
  11. Effect of Electronic Nicotine Delivery Systems on Cigarette Abstinence in Smokers With No Plans to Quit: Exploratory Analysis of a Randomized Placebo-Controlled Trial
  12. Electronic cigarettes for smoking cessation
  13. The Cochrane review of electronic cigarettes for smoking cessation: remaining focused on the evidence
  14. A systematic review of group therapy programs for smoking cessation in Asian countries
  15. Effect of an electronic nicotine delivery system with 0, 8, or 36 mg/mL liquid nicotine versus a cigarette substitute on tobacco-related toxicant exposure: a four-arm, parallel-group, randomised, controlled trial
  16. Increases in early discharge following acute coronary syndrome hospitalisations and associated clinical outcomes in New Zealand between 2006 and 2015: ANZACS‐QI ‐43 study
  17. Physiologically Based Pharmacokinetic Modelling for Nicotine and Cotinine Clearance in Pregnant Women
  18. Mobility restrictions were associated with reductions in COVID-19 incidence early in the pandemic: evidence from a real-time evaluation in 34 countries
  19. Targeted smoking cessation for dual users of combustible and electronic cigarettes: a randomised controlled trial
  20. Effect of Electronic Nicotine Delivery Systems on Cigarette Abstinence in Smokers with no Plans to Quit: Exploratory Analysis of a Randomized Placebo-Controlled Trial
  21. Institutional and behaviour-change interventions to support COVID-19 public health measures: a review by the Lancet Commission Task Force on public health measures to suppress the pandemic
  22. Cytisine versus varenicline for smoking cessation in New Zealand indigenous Māori: a randomized controlled trial
  23. Electronic cigarettes for smoking cessation
  24. Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand
  25. The Potential Effectiveness of COVID-Related Smoking Cessation Messages in Three Countries
  26. Harm Perceptions of E-cigarette Use Among New Zealand Young People: Development of a Questionnaire
  27. Development of a Self-Help Smoking Cessation Intervention for Dual Users of Tobacco Cigarettes and E-Cigarettes
  28. See How They Grow: Testing the feasibility of a mobile app to support parents’ understanding of child growth charts
  29. Prescribed exercise regimen versus usual care and hypochlorous acid wound solution versus placebo for treating venous leg ulcers: study protocol for a randomised controlled trial (Factorial4VLU)
  30. Charting elimination in the pandemic: a SARS-CoV-2 serosurvey of blood donors in New Zealand
  31. Real World Evidence of Trace, Test, Isolation, and Quarantine Impact on the COVID-19 Pandemic Response Performance
  32. The Impact of COVID-19 on the Care of Patients With Noncommunicable Diseases in Low- and Middle-Income Countries: An Online Survey of Patient Perspectives
  33. The impact of COVID-19 on the care of people living with noncommunicable diseases in low- and middle-income countries: an online survey of physicians and pharmacists in nine countries
  34. Towards the Objective Speech Assessment of Smoking Status based on Voice Features: A Review of the Literature
  35. A randomized trial comparing the acute coronary, systemic, and environmental effects of electronic vaping cigarettes versus heat-not-burn cigarettes in smokers of combustible cigarettes undergoing invasive coronary assessment: rationale and design of t...
  36. How well does societal mobility restriction help control the COVID-19 pandemic? Evidence from real-time evaluation
  37. Mobile Social Network–Based Smoking Cessation Intervention for Chinese Male Smokers: Pilot Randomized Controlled Trial
  38. Tobacco Use and Cessation Among a National Online Sample of Men Who Have Sex With Men in Malaysia
  39. Electronic cigarettes for smoking cessation
  40. A Mobile Social Network–Based Smoking Cessation Intervention for Chinese Male Smokers: Protocol for a Pilot Randomized Controlled Trial
  41. Preferences for Tobacco Cessation Information and Support During Covid-19
  42. Trends in cardiovascular outcomes after acute coronary syndrome in New Zealand 2006–2016
  43. Real-world unassisted quit success and related contextual factors: a population-based study of Chinese male smokers
  44. Wool-derived keratin dressings versus usual care dressings for treatment of slow healing venous leg ulceration: a randomised controlled trial (Keratin4VLU)
  45. Betel Nut Use in Vanuatu: Investigating Opportunities to Reduce Harms to Health
  46. E-learning: A Tool to Upgrade the Skills of Health Workers to Address Betel Quid and Areca Nut Chewing
  47. A call for greater policy and regulatory coherence for an expanding menu of legal psychoactive substances
  48. Considering the health and social welfare impacts of non‐medical cannabis legalization
  49. Use of e-cigarettes and smoked tobacco in youth aged 14–15 years in New Zealand: findings from repeated cross-sectional studies (2014–19)
  50. Nicotine patches with e-cigarettes for smoking cessation: Twitter discussion from a respirology journal club – Authors' reply
  51. Manaaki – a cognitive behavioral therapy mobile health app to support people experiencing gambling problems: a randomized control trial protocol
  52. Emerging prospects for non-medical cannabis legalisation in New Zealand: An initial view and contextualization
  53. Housing structure and occupant behaviour to increase the environmental and health co-benefits of housing: Insights from expert interviews in New Zealand
  54. How Well Does Societal Mobility Restriction Help Control the COVID-19 Pandemic? Evidence from Real-Time Evaluation
  55. Nicotine patches used in combination with e-cigarettes (with and without nicotine) for smoking cessation: a pragmatic, randomised trial
  56. Prevalence of invasive cancer in a large general practice patient population in New Zealand
  57. See How They Grow: Testing the Feasibility of a Mobile App to Support Parents' Understanding of Child Growth Charts
  58. Development of MyTeen Text Messaging Program to Support Parents of Adolescents: Qualitative Study
  59. Mobile phone text messaging and app-based interventions for smoking cessation
  60. Investigating Betel Nut Use, Antecedents and Consequences: A Review of Literature
  61. Effect of MyTeen SMS-Based Mobile Intervention for Parents of Adolescents
  62. The mobile-phone-based iCO<sup>TM</sup> Smokerlyzer<sup>®</sup>: Comparison with the piCO<sup>+</sup> Smokerlyzer<sup>®</sup> among smokers undergoing methadone-maintained therapy
  63. Defining and Measuring Abstinence in Clinical Trials of Smoking Cessation Interventions: An Updated Review
  64. Subcutaneous nicotine delivery via needle-free jet injection: A porcine model
  65. Erratum: How Does Smoking and Nicotine Dependence Change After Onset of Vaping? A Retrospective Analysis of Dual Users
  66. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation
  67. Acute Effects of Heat‐Not‐Burn, Electronic Vaping, and Traditional Tobacco Combustion Cigarettes: The Sapienza University of Rome‐Vascular Assessment of Proatherosclerotic Effects of Smoking (SUR‐VAPES) 2 Randomized Trial
  68. How Does Smoking and Nicotine Dependence Change After Onset of Vaping? A Retrospective Analysis of Dual Users
  69. Correction: Socio-economic status and behavioural and cardiovascular risk factors in Papua New Guinea: A cross-sectional survey
  70. Vaping characteristics and expectancies are associated with smoking cessation propensity among dual users of combustible and electronic cigarettes
  71. Effectiveness and safety of nicotine patches combined with e-cigarettes (with and without nicotine) for smoking cessation: study protocol for a randomised controlled trial
  72. Socio-economic status and behavioural and cardiovascular risk factors in Papua New Guinea: A cross-sectional survey
  73. Ascending single dose pharmacokinetics of cytisine in healthy adult smokers
  74. Impact of Tobacco Versus Electronic Cigarette Smoking on Platelet Function
  75. Measurement of Electronic Cigarette Frequency of Use Among Smokers Participating in a Randomized Controlled Trial
  76. Evaluation of MyTeen – a SMS-based mobile intervention for parents of adolescents: a randomised controlled trial protocol
  77. Cytisine versus varenicline for smoking cessation for Māori (the indigenous people of New Zealand) and their extended family: protocol for a randomised non-inferiority trial.
  78. A Stability Indicating HPLC Method to Determine Actual Content and Stability of Nicotine within Electronic Cigarette Liquids
  79. Reaching cardiovascular prevention guideline targets with a polypill-based approach: a meta-analysis of randomised clinical trials
  80. Nicotine replacement therapy versus control for smoking cessation
  81. Predictors of oxidative stress and vascular function in an experimental study of tobacco versus electronic cigarettes: A post hoc analysis of the SUR-VAPES 1 Study
  82. The effectiveness and safety of combining varenicline with nicotine e-cigarettes for smoking cessation in people with mental illnesses and addictions: study protocol for a randomised-controlled trial
  83. Free standing PEDOT films prepared by vapour phase polymerisation as electrically tuneable barriers to drug permeability
  84. Impact of venous leg ulceration on health-related quality of life: A synthesis of data from randomized controlled trials compared to population norms
  85. Wool-derived keratin dressings versus usual care dressings for treatment of slow-healing venous leg ulceration: study protocol for a randomised controlled trial (Keratin4VLU)
  86. Predicting Short-Term Uptake of Electronic Cigarettes: Effects of Nicotine, Subjective Effects, and Simulated Demand
  87. Impact of switching to polypill based therapy by baseline potency of medication: Post-hoc analysis of the SPACE Collaboration dataset
  88. Low dose aspirin as adjuvant treatment for venous leg ulceration: pragmatic, randomised, double blind, placebo controlled trial (Aspirin4VLU)
  89. Rise in e-cigarette use linked to increase in smoking cessation rates
  90. No single intervention will solve the obesity epidemic – RACP physicians and paediatricians exploring points in the life cycle to prevent and manage obesity for children and families
  91. Online Smoking Cessation Advertising and Young Pacific Smokers in New Zealand
  92. A randomized controlled trial of a smoking cessation self-help intervention for dual users of tobacco cigarettes and E-cigarettes: Intervention development and research design
  93. E-cigarettes and Urologic Health: A Collaborative Review of Toxicology, Epidemiology, and Potential Risks
  94. Prevalence of non-communicable disease risk factors in three sites across Papua New Guinea: a cross-sectional study
  95. The impact of a point-of-care testing device on CVD risk assessment completion in New Zealand primary-care practice: A cluster randomised controlled trial and qualitative investigation
  96. A Comparative Health Risk Assessment of Electronic Cigarettes and Conventional Cigarettes
  97. Economic evaluation of an exercise-counselling intervention to enhance smoking cessation outcomes: The Fit2Quit trial
  98. An evaluation of a harm reduction Summer School for undergraduate health professional students
  99. Challenges in Building, Funding, and Conducting a Pragmatic Randomized Controlled Trial of Aspirin for Treating Venous Leg Ulcers
  100. Reducing the nicotine content of combusted tobacco products sold in New Zealand
  101. Electronic cigarettes for smoking cessation
  102. Using a videotaped objective structured clinical examination to assess Knowledge In Smoking cessation amongst medical Students (the K.I.S.S. Study)
  103. E-cigarettes and nicotine dependence
  104. Getting cytisine licensed for use world-wide: a call to action
  105. Polypill-based therapy likely to reduce ethnic inequities in use of cardiovascular preventive medications: Findings from a pragmatic randomised controlled trial
  106. Do polypills lead to neglect of lifestyle risk factors? Findings from an individual participant data meta-analysis among 3140 patients at high risk of cardiovascular disease
  107. E-Cigarettes and Smoking Cessation
  108. E-cigarettes and smoking cessation
  109. Mobile phone-based interventions for smoking cessation
  110. Effectiveness of fixed dose combination medication (‘polypills’) compared with usual care in patients with cardiovascular disease or at high risk: A prospective, individual patient data meta-analysis of 3140 patients in six countries
  111. Using run charts for cardiovascular disease risk assessments in general practice
  112. E-cigarettes in smoking cessation: a harm reduction perspective
  113. Low-dose aspirin as an adjuvant treatment for venous leg ulceration: study protocol for a randomized controlled trial (Aspirin4VLU)
  114. An intervention to reduce the number of convenience stores selling tobacco: feasibility study
  115. Cytisine Versus Nicotine for Smoking Cessation
  116. E-cigarettes versus NRT for smoking reduction or cessation in people with mental illness: secondary analysis of data from the ASCEND trial
  117. A systematic review of barriers and facilitators to participation in randomized controlled trials by Indigenous people from New Zealand, Australia, Canada and the United States
  118. Guidance to Employers on Integrating E-Cigarettes/Electronic Nicotine Delivery Systems Into Tobacco Worksite Policy
  119. Cytisine versus Nicotine for Smoking Cessation
  120. Electronic cigarettes for smoking cessation and reduction
  121. Issues in regulating E-cigarette clinical research
  122. Abrupt nicotine reduction as an endgame policy: a randomised trial
  123. Electronic Cigarettes for Smoking Cessation
  124. Effects of exercise on the desire to smoke and physiological responses to temporary smoking abstinence: a crossover trial
  125. Effect of a Family-Centered, Secondhand Smoke Intervention to Reduce Respiratory Illness in Indigenous Infants in Australia and New Zealand: A Randomized Controlled Trial
  126. Electronic Cigarettes: A Policy Statement From the American Heart Association
  127. An Exercise Programme for Smoking Cessation: Perceptions of the Fit2quit Trial Intervention
  128. Parental and retail supply of tobacco to minors: Findings from a community-based social supply intervention study
  129. Operational research in the South Pacific
  130. Context on Use Is Needed Before Public Health Recommendations Are Made About E-Cigarettes
  131. Effect of fixed dose combination treatment on adherence and risk factor control among patients at high risk of cardiovascular disease: randomised controlled trial in primary care
  132. Knowledge and practices of tobacco dependence treatment among junior doctors in a Malaysian teaching hospital
  133. Evidence, not conjecture, should guide clinical practice and policies on e-cigarettes
  134. Exercise Counseling to Enhance Smoking Cessation Outcomes: The Fit2Quit Randomized Controlled Trial
  135. Electronic Cigarettes for Smoking Cessation: A Randomised Controlled Trial
  136. Electronic cigarettes and smoking cessation: a quandary? – Authors' reply
  137. A longitudinal study of electronic cigarette users
  138. Tobacco Control Questionnaire
  139. Using Health Rights to Design Aid-Funded Health Programs so They First do no Harm
  140. Protecting children from taking up smoking: parents' views on what would help
  141. Prevalence and risk factors for tobacco smoking among pre-adolescent Pacific children in New Zealand
  142. Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: The SPACE Collaboration
  143. Electronic cigarettes for smoking cessation: a randomised controlled trial
  144. Improving Health Worker Adherence to Malaria Treatment Guidelines in Papua New Guinea: Feasibility and Acceptability of a Text Message Reminder Service
  145. A Cochrane systematic review of the effectiveness of organisational travel plans: Improving the evidence base for transport decisions
  146. Transition to a smoke-free culture within mental health and drug and alcohol services: A survey of key stakeholders
  147. Smoking cessation and respiratory disease in low-income and middle-income countries
  148. Anti-acid treatment for idiopathic pulmonary fibrosis
  149. Primary school compliance with school canteen guidelines in Fiji and its association with student obesity
  150. Trends in cervical cancer in Fiji, 2000–2010
  151. Study protocol for a randomised controlled trial of electronic cigarettes versus nicotine patch for smoking cessation
  152. Recruiting equal numbers of indigenous and non-indigenous participants to a ‘polypill’ randomized trial
  153. Impact of national smokefree environments laws on teachers, schools and early childhood centres
  154. Nicotine replacement therapy for smoking cessation
  155. Mobile phone-based interventions for smoking cessation
  156. Electronic cigarettes for smoking cessation and reduction
  157. The combined effect of very low nicotine content cigarettes, used as an adjunct to usual Quitline care (nicotine replacement therapy and behavioural support), on smoking cessation: a randomized controlled trial
  158. The acute effects of exercise on cigarette cravings, withdrawal symptoms, affect, and smoking behaviour: systematic review update and meta-analysis
  159. Views From a Small Pacific Island
  160. Study protocol for a non-inferiority trial of cytisine versus nicotine replacement therapy in people motivated to stop smoking
  161. Driving kids to smoke? Children's reported exposure to smoke in cars and early smoking initiation
  162. Saliva cotinine levels in users of electronic cigarettes
  163. Turning Postgraduate Students’ Research Into Publications
  164. Electronic cigarette: users profile, utilization, satisfaction and perceived efficacy
  165. Does improved access and greater choice of nicotine replacement therapy affect smoking cessation success? Findings from a randomized controlled trial
  166. How can we best intervene in the trip to school? Pathways from transport to health
  167. Publications as an Indicator of Increased Tobacco Control Research Productivity (Quantity and Quality) in New Zealand
  168. Electronic nicotine delivery systems: a research agenda
  169. A Theory-Based Video Messaging Mobile Phone Intervention for Smoking Cessation: Randomized Controlled Trial
  170. Study protocol for a randomised trial of nicotine-free cigarettes as an adjunct to usual NRT-based cessation practice, in people who wish to stop smoking
  171. Electronic Cigarette Attitudes Questionnaire
  172. Smoking is rank! But, not as rank as other drugs and bullying say New Zealand parents of pre-adolescent children
  173. The respiratory health effects of nitrogen dioxide in children with asthma
  174. Design and conduct of a pragmatic randomized controlled trial to enhance smoking-cessation outcomes with exercise: The Fit2Quit study
  175. Use of a national quitline and variation in use by smoker characteristics: ITC Project New Zealand
  176. Harnessing Health IT for Improved Cardiovascular Risk Management
  177. Pre-cessation nicotine replacement therapy: pragmatic randomized trial
  178. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomised cross-over trial
  179. Organisational travel plans for improving health
  180. The study protocol for a randomized controlled trial of a family-centred tobacco control program about environmental tobacco smoke (ETS) to reduce respiratory illness in Indigenous infants
  181. A randomized trial of the effects of two novel nicotine replacement therapies on tobacco withdrawal symptoms and user satisfaction
  182. Mobile phone-based interventions for smoking cessation
  183. Environmental influences on food security in high-income countries
  184. Impact on quit attempts of mailed general practitioner 'brief advice' letters plus nicotine replacement therapy vouchers
  185. Mobile phone-based interventions for smoking cessation
  186. Reduced–nicotine content cigarettes: Is there potential to aid smoking cessation?
  187. A single-blind, randomized, crossover trial of the effects of a nicotine pouch on the relief of tobacco withdrawal symptoms and user satisfaction
  188. Cigarette fires and burns in a population of New Zealand smokers
  189. Keeping Kids Smokefree: Rationale, Design, and Implementation of a Community, School, and Family-Based Intervention to Modify Behaviors Related to Smoking Among Māori and Pacific Island Children in New Zealand
  190. Educating public health physicians for the future: a current perspective from Aotearoa New Zealand
  191. The environment and physical activity: The influence of psychosocial, perceived and built environmental factors
  192. A Multimedia Mobile Phone–Based Youth Smoking Cessation Intervention: Findings From Content Development and Piloting Studies
  193. Hepatitis B in a high prevalence New Zealand population: A mathematical model applied to infection control policy
  194. Effects of improved home heating on asthma in community dwelling children: randomised controlled trial
  195. A Near Miss: The Importance of Context in a Public Health Informatics Project in a New Zealand Case Study
  196. Organisational travel plans for improving health
  197. Impact of tobacco smoking and smoking cessation on cardiovascular risk and disease
  198. Supermarket Sales Data: Feasibility and Applicability in Population Food and Nutrition Monitoring
  199. Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status
  200. An Evaluation of the Activity of Smoking Cessation Practitioners in New Zealand Following Smoking Cessation Training
  201. Recruitment Into a Cessation Trial Via the New Zealand Quitline: Many Benefits, Few Limitations
  202. Bringing health home: Householder and provider perspectives on the healthy housing programme in Auckland, New Zealand
  203. After the smoke has cleared: evaluation of the impact of a new national smoke-free law in New Zealand
  204. Nicotine replacement therapy for smoking cessation
  205. Measuring Health Equity in Small Areas: Findings from Demographic Surveillance Systems
  206. Mobile phone-based interventions for smoking cessation
  207. Supermarket Sales Data: Feasibility and Applicability in Population Food and Nutrition Monitoring
  208. A survey of New Zealand's Territorial Local Authorities' policies, plans and programs promoting physical activity
  209. Factors Associated With Regular Eye Examinations in People With Diabetes: Results From the Victorian Population Health Survey
  210. Organisational travel plans for improving health
  211. Pre-quitting nicotine replacement therapy: Findings from a pilot study
  212. Pre-quitting nicotine replacement therapy: Findings from a pilot study
  213. Using Nicotine Replacement Therapy to Assist in Reducing Cigarette Consumption before Quitting
  214. Nicotine replacement therapy for smoking cessation
  215. Taking Public Health to the Streets: The 1998 Auckland Meningococcal Disease Awareness Program
  216. Matching tidal current plants to local flow conditions
  217. Ethnic differences in coronary heart disease case fatality rates in Auckland
  218. Ethnic differences in coronary heart disease case fatality rates in Auckland